OxyContin was submitted and justifiably approved by the agency as a 12-hour dosage form

Jeffrey Fudin, Mena Raouf, Erica Wegrzyn
  • Journal of Pain Research, September 2016, Dove Medical Press
  • DOI: 10.2147/jpr.s117219

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

open access logoRead Publication

http://dx.doi.org/10.2147/jpr.s117219

The following have contributed to this page: Dr Jeffrey Fudin and Dr. Erica L. Wegrzyn